OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the Pancreas
Clinical trial NCT01600807 · WITHDRAWN
Trial details
- NCT number
- NCT01600807
- Sponsor
- Dana-Farber Cancer Institute
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.